Download Reference Coordinates Table 1F

LIST OF PUBLICATIONS REFERRED TO
IN THE 23RD EDITION (2012 – 2013) OF THE BELGIUM – LUXEMBOURG VERSION
OF THE SANFORDGUIDE TO ANTIMICROBIAL THERAPY
1F.1
1F.2
1F.3
1F.4
1F.5
1F.6
1F.7
1F.8
1F.9
1F.10
1F.11
1F.12
1F.13
1F.14
1F.15
1F.16
1F.17
1F.18
1F.19
1F.20
1F.21
1F.22
1F.23
1F.24
1F.25
1F.26
1F.27
1F.28
1F.29
1F.30
1F.31
1F.32
1F.33
1F.34
1F.35
1F.36
1F.37
1F.38
1F.39
1F.40
1F.41
1F.42
TABLE 1F
BACTERIAL INFECTIONS: TREATMENT OF INFECTIONS OF THE EYE
Kowalski RP, Dhaliwal DK. Ocular bacterial infections: current and future treatment options. Expert
Rev Anti Infect Ther 2005;3:131-9.
Thomas PA. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev 2003;16:730-97.
Leibowitz HM. The red eye. N Engl J Med 2000;343:345-51.
Kodjikian L, Dufour JF, Nguyen AM, Sève P. Ocular zoonoses. Expert Rev Ophthalmol 2009;4:33149.
Mueller JB, McStay CM. Ocular infection and inflammation. Emerg Med Clin North Am 2008;26:5772.
Garg P. Fungal, mycobacterial, and Nocardia infections and the eye: an update. Eye 2012;26:24551.
Bernardes TF, Bonfioli AA. Blepharitis. Semin Ophthalmol 2010;25:79-83.
Fulmer NL, Neal JG, Bussard GM, Edlich RF. Lacrimal canaliculitis. Am J Emerg Med 1999;17:3856.
Freedman JR, Markert MS, Cohen AJ. Primary and secondary lacrimal canaliculits: a review of literature. Surv Ophthalmol 2011;56:336-47.
Kloek CE, Rubin PA. Role of inflammation in orbital cellulitis. Int Ophthalmol Clin 2006;46(2):57-68.
Wald ER. Periorbital (preseptal) cellulitis in children. Expert Rev Ophthalmol 2008;3:645-54.
Nageswaran S, Woods CR, Benjamin DK, Givner LB, Shetty AK. Orbital cellulitis in children. Pediatr
Infect Dis J 2006;25:695-9.
Bilyk JR. Periocular infection. Curr Opin Ophthalmol 2007;18:414-23.
Rudloe TF, Harper MB, Prabhu SP, Rahbar R, Vanderveen D, Kimia AA. Acute periorbital infections:
who needs emergent imaging? Pediatrics 2010;125:e719-26.
Baring DE, Hilmi OJ. An evidence based review of orbital cellulitis. Clin Otolaryngol 2011;36;57-64.
Wald ER. Periorbital and orbital infections. Infect Dis Clin North Am 2007;21:393-408.
Soon VT. Pediatric subperiostal orbital abscess secondary to acute sinusitis: a 5-year review. Am J
Otolaryngol Head Neck Surg 2011;32:62-8.
Seltz LB, Smith J, Durairaj VD, Enzenauer R, Todd J. Microbiology and antibiotic management of
orbital cellulitis. Pediatrics 2011;127:e566-72.
Bedwell J, Bauman NM. Management of pediatric orbital cellulitis and abscess. Curr Opin Otolaryngol Head Neck Surg 2011;19:467-73.
Everitt HA, Little PS, Smith PW. A randomised controlled trial of management strategies for acute
bacterial conjunctivitis in general practice. Br Med J 2006;333:321-4.
Høvding G. Acute bacterial conjunctivitis. Acta Ophthalmol 2008;86:5-17.
Rose P. Management strategies for acute infective conjunctivitis in primary care: a systematic review.
Expert Opin Pharmacother 2007;8:1903-21.
Sheikh A, Hurwitz B, van Schayck CP, McLean S, Nurmatov U. Antibiotics versus placebo for acute
bacterial conjunctivitis. Cochrane Database Syst Rev 2012;9:CD001211.
Sheikh A, Hurwitz B. Topical antibiotics for acute bacterial conjunctivitis: Cochrane systematic review
and meta-analysis update. Br J Gen Pract 2005;55:962-4.
Woods CR. Gonococcal infections in infants and young children. Semin Pediatr Infect Dis 2005;16:
258-70.
Rours IG, Hammerschlag MR, Ott A, De Faber TJ, Verbrugh HA, de Groot R, Verkooyen RP. Chlamydia trachomatis as a cause of neonatal conjunctivitis in Dutch infants. Pediatrics 2008;121:e3216.
Darville T. Chlamydia trachomatis infections in neonates and young children. Semin Pediatr Infect
Dis 2005;16:235-44.
Jefferis J, Perera R, Everitt H, van Weert H, Rietveld R, Glasziou P, Rose P. Acute infective conjunctivitis in primary care: who needs antibiotics? An individual patient data meta-analysis. Br J Gen
Pract 2006;11:e542-6.
Gambhir M, Basáñez MG, Turner F, Kumaresan J, Grassly NC. Trachoma: transmission, infection,
and control. Lancet Infect Dis 2007;7:420-7.
Wright HR. Trachoma. Lancet 2008:371:1945-54.
Solomon AW, Peeling RW, Foster A, Mabey DC. Diagnosis and assessment of trachoma. Clin Microbiol Rev 2004;17:982-1011.
Schwartz SG, Flynn HW, Scott IU. Endophthalmitis: classification and current management. Expert
Rev Ophthalmol 2007;2:385-96.
Callegan MC, Engelbert M, Parke DW, Jett BD, Gilmore MS. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium host interactions. Clin Microbiol Rev 2002;15:111-24.
Aiello LP, Brucker AJ, Chang S, Cunningham ET Jr, D'Amico DJ, Flynn HW Jr, Grillone LR, Hutcherson S, Liebmann JM, O'Brien TP, Scott IU, Spaide RF, Ta C, Trese MT. Evolving guidelines for intravitreous injections. Retina 2004;24(suppl. 5):S3-19.
Novosad BD, Callegan MC. Severe bacterial endophthalmitis: towards improving clinical outcomes.
Expert Rev Ophthalmol 2010;5:689-98.
Lemley CA, Han DP. Endophthalmitis. A review of current evaluation and management. Retina 2007;
27:662-80.
López-Cabezas C, Muner DS, Massa MR, Mensa Pueyo JM. Antibiotics in endophthalmitis: microbiological and pharmacokinetic considerations. Curr Clin Pharmacol 2010;5:47-54.
Khairallah M, Chee SP, Rathinam SR, Attia S, Nadella V. Novel infectious agents causing uveitis. Int
Ophthalmol 2010;30:465-83.
Chhablani J. Fungal endophthalmitis. Expert Rev Anti Infect Ther 2011;9:1191-201.
Roth DB, Flynn HW. Antibiotic selection in the treatment of endophthalmitis: the significance of drug
combinations and synergy. Surv Ophthalmol1997;41:395-401.
Galloway G, Ramsay A, Jordan K, Vivian A. Macular infarction after intravitreal amikacin: mounting
evidence against amikacin. Br J Ophthalmol 2002;86:359-60.
Galloway G, Ramsay A, Jordan K, Vivian A. Macular infarction after intravitreal amikacin: mounting
evidence against amikacin. Br J Ophthalmol 2002;86:359-60.
1F.43
1F.44
1F.45
1F.46
1F.47
1F.48
1F.49
1F.50
1F.51
1F.52
1F.53
1F.54
1F.55
1F.56
1F.57
1F.58
1F.59
1F.60
1F.61
1F.62
1F.63
1F.64
Sallam A, Lynn W, McCluskey P, Lightman S. Endogenous Candida endophthalmitis. Expert Rev
Anti Infect Ther 2006:4:675-85.
Shah CP, McKey J, Spirn MJ, Maguire J. Ocular candidiasis: a review. Br J Ophthalmol 2008;92:
466-8.
Busbee BG. Endophthalmitis: A reappraisal of incidence and treatment. Curr Opin Ophthalmol
2006;17:287-91.
Hanscom TA. Postoperative endophthalmitis. Clin Infect Dis 2004;38:542-6.
Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative
bacterial endophthalmitis. Arch Ophthalmol 1995;113:1479-96.
Galloway G, Ramsay A, Jordan K, Vivian A. Macular infarction after intravitreal amikacin: mounting
evidence against amikacin. Br J Ophthalmol 2002;86:359-60.
Galloway G, Ramsay A, Jordan K, Vivian A. Macular infarction after intravitreal amikacin: mounting
evidence against amikacin. Br J Ophthalmol 2002;86:359-60.
Bhagat N, Nagori S, Zarbi M. Post-traumatic infectious endophthalmitis. Surv Opthalmol 2011;56:
214-51.
Galloway G, Ramsay A, Jordan K, Vivian A. Macular infarction after intravitreal amikacin: mounting
evidence against amikacin. Br J Ophthalmol 2002;86:359-60.
Lindsley K, Nichols JJ, Dickersin K. Interventions for acute internal hordeolum. Cochrane Database
Syst Rev 2010;9:CD007742.
Thomas PA, Geraldine P. Infectious keratitis. Curr Opin Infect Dis 2007;20:129-41.
Panda A, Vanathi M. Management approach for bacterial and fungal corneal ulcers. Expert Rev
Ophthalmol 2008;3:471-9.
Suwan-Apichon O, Reyes JM, Herretes S, Vedula SS, Chuck RS. Topical corticosteroids as adjunctive therapy for bacterial keratitis. Cochrane Database Syst Rev 2007;4:CD005430.
Shah VM, Tandon R, Satpathy G, Nayak N, Chawla B, Agarwal T, Sharma N, Titiyal JS, Vajpayee
RB. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with
the combination of fortified antibiotics in the treatment of bacterial corneal ulcers. Cornea 2010;29:
751-7.
FlorCruz NV, Peczon IV, Evans JR. Medical interventions for fungal keratitis. Cochrane Database
Syst Rev 2012;2:CD004241.
Shukla PK, Kumar M, Keshava GB. Mycotic keratitis: an overview of diagnosis and therapy. Mycoses
2008;51:183-99.
Prakash G, Sharma N, Goel M, Titiyal JS, Vajpayee RB. Evaluation of intrastromal injection of voriconazole as therapeutic adjunctive for the management of deep recalcitrant fungal keratitis. Am J
Ophthalmol 2008;146:56-9.
Dart J, Saw VP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment. Update 2009. Am J
Ophthalmol 2009;148:487-99.
Hammersmith KM. Diagnosis and management of Acanthamoeba keratitis. Curr Opin Ophthalmol
2006;17:327-31.
Awwad ST, Petroll WM, McCulley JP, Cavanagh HD. Updates in Acanthamoeba keratitis. Eye Contact Lens 2007;33:1-8.
Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol
Rev 2003;16:273-307.
Seal D. Treatment of Acanthamoeba keratitis. Expert Rev Anti Infect Ther 2003;1:205-8.